Search research articles
Contact Us
Filters
Showing results (261-270 of 280) with videos related to
Page
of 28
Sort By:
Blood Cell Therapy
|
December 27, 2023
Report on hematopoietic cell transplantations performed in 2018/2019 focusing on the trends of selection of stem cell sources in the Asia-Pacific region: APBMT Activity Survey
Minako Iida, Kaiyan Liu, Xiao Jun Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 18, 2018
Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
Ho-Young Yhim, Yong Park, Yeon-Hee Han, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 30, 2018
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
Ho-Young Yhim, Yong Park, Yeon-Hee Han, et al.
Blood Cancer Journal
|
June 26, 2023
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation
Dong Won Baek, Joon Ho Moon, Jae Hoon Lee, et al.
American Journal of Hematology
|
August 1, 2015
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
Sung-Nam Lim, Young-Don Joo, Kyoo-Hyung Lee, et al.
Diabetes & Metabolism Journal
|
October 4, 2023
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, et al.
Med (New York, N.Y.)
|
April 7, 2026
Comparative efficacy of phase 2-3 therapies for non-cirrhotic metabolic dysfunction-associated steatohepatitis: An updated network meta-analysis
Tsubasa Tsutsumi, Nicole Shu Ying Tang, Cheng Han Ng, et al.
Leukemia & Lymphoma
|
April 6, 2011
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia
Sang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, et al.
Cancer Medicine
|
March 27, 2018
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea
Junghoon Shin, Youngil Koh, Seo Hyun Yoon, et al.
International Journal of Hematology
|
July 6, 2014
Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients
Soo-Jeong Kim, June-Won Cheong, Dae-Young Kim, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 280) with videos related to
Sort By:
Page
of 28
Blood Cell Therapy
|
December 27, 2023
Report on hematopoietic cell transplantations performed in 2018/2019 focusing on the trends of selection of stem cell sources in the Asia-Pacific region: APBMT Activity Survey
Minako Iida, Kaiyan Liu, Xiao Jun Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 18, 2018
Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
Ho-Young Yhim, Yong Park, Yeon-Hee Han, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 30, 2018
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
Ho-Young Yhim, Yong Park, Yeon-Hee Han, et al.
Blood Cancer Journal
|
June 26, 2023
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation
Dong Won Baek, Joon Ho Moon, Jae Hoon Lee, et al.
American Journal of Hematology
|
August 1, 2015
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
Sung-Nam Lim, Young-Don Joo, Kyoo-Hyung Lee, et al.
Diabetes & Metabolism Journal
|
October 4, 2023
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, et al.
Med (New York, N.Y.)
|
April 7, 2026
Comparative efficacy of phase 2-3 therapies for non-cirrhotic metabolic dysfunction-associated steatohepatitis: An updated network meta-analysis
Tsubasa Tsutsumi, Nicole Shu Ying Tang, Cheng Han Ng, et al.
Leukemia & Lymphoma
|
April 6, 2011
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia
Sang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, et al.
Cancer Medicine
|
March 27, 2018
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea
Junghoon Shin, Youngil Koh, Seo Hyun Yoon, et al.
International Journal of Hematology
|
July 6, 2014
Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients
Soo-Jeong Kim, June-Won Cheong, Dae-Young Kim, et al.
Page
of 28